Association between chronic hepatitis B infection and COVID-19 outcomes: A Korean nationwide cohort study.
Background/aimsWe measured Ammonia Removers the association between underlying chronic hepatitis B (CHB) and antiviral use with infection rates among patients who underwent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing.MethodsIn total, 204,418 patients who were tested for SARS-CoV-2 between January and June 2020 were included